Ovary Cancer Tissue Array, With Adjacent Normal Tissue, Including TNM And Pathology Grade, 70 Cases/70 Cores、replaced By OV702a|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:172708

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Ovary Cancer Tissue Array, With Adjacent Normal Tissue, Including TNM And Pathology Grade, 70 Cases/70 Cores、replaced By OV702a)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月16日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年05月16日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Ovarial carcinoma tissue microarray, containing 60 cases of adenocarcinoma, 10 adjacent normal tissue, single core per case
Cores: 70
組織アレイ
Cases: 70
Layout: 10 cols × 7 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Actin confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 26 Ovary Serous papillary adenocarcinoma 1 Ic T1cN0M0 Malignant
A2 2 F 34 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
A3 3 F 50 Ovary Serous papillary adenocarcinoma 1 IIa T2aN0M0 Malignant
A4 4 F 58 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
A5 5 F 65 Ovary Serous papillary adenocarcinoma 1 IIa T2aN0M0 Malignant
A6 6 F 65 Ovary Serous papillary adenocarcinoma 1 Ia T1aN0M0 Malignant
A7 7 F 39 Ovary Serous adenocarcinoma 1 Ia T1aN0M0 Malignant
A8 8 F 53 Ovary Serous adenocarcinoma with necrosis 3 Ia T1aN0M0 Malignant
A9 9 F 40 Ovary Serous adenocarcinoma 3 IIa T2aN0M0 Malignant
A10 10 F 54 Ovary Serous adenocarcinoma 2 IIa T2aN0M0 Malignant
B1 11 F 37 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
B2 12 F 68 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B3 13 F 36 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
B4 14 F 50 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
B5 15 F 59 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
B6 16 F 61 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
B7 17 F 60 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
B8 18 F 45 Ovary Serous papillary adenocarcinoma 2 IIIc T2N1M0 Malignant
B9 19 F 27 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
B10 20 F 53 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
C1 21 F 54 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
C2 22 F 52 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
C3 23 F 64 Ovary Serous papillary adenocarcinoma 2 IV T3N1M1 Malignant
C4 24 F 58 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
C5 25 F 51 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
C6 26 F 66 Ovary Serous papillary adenocarcinoma 2 Ic T1cN0M0 Malignant
C7 27 F 47 Ovary Serous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
C8 28 F 57 Ovary Serous papillary adenocarcinoma 2 IIa T2aN0M0 Malignant
C9 29 F 58 Ovary Serous papillary adenocarcinoma 2 IIIc T3cN1M0 Malignant
C10 30 F 48 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
D1 31 F 63 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
D2 32 F 69 Ovary Serous adenocarcinoma 2 II T2N0M0 Malignant
D3 33 F 52 Ovary Serous papillary adenocarcinoma 3 II T2N0M0 Malignant
D4 34 F 58 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
D5 35 F 57 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
D6 36 F 51 Ovary Serous papillary adenocarcinoma 2 Ib T1bN0M0 Malignant
D7 37 F 41 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
D8 38 F 52 Ovary Serous papillary adenocarcinoma 3 Ic T1cN0M0 Malignant
D9 39 F 41 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
D10 40 F 60 Ovary Serous papillary adenocarcinoma 3 Ia T1aN0M0 Malignant
E1 41 F 70 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
E2 42 F 51 Ovary Serous papillary adenocarcinoma 3 Ic T1cN0M0 Malignant
E3 43 F 53 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
E4 44 F 62 Ovary Serous papillary adenocarcinoma 3 Ib T1bN0M0 Malignant
E5 45 F 48 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
E6 46 F 59 Ovary Serous papillary adenocarcinoma 2 IIb T2bN0M0 Malignant
E7 47 F 44 Ovary Serous papillary adenocarcinoma 3 IIa T2aN0M0 Malignant
E8 48 F 49 Ovary Mucinous adenocarcinoma 1 Ia T1aN0M0 Malignant
E9 49 F 45 Ovary Mucinous adenocarcinoma 1 Ia T1aN0M0 Malignant
E10 50 F 48 Ovary Mucinous adenocarcinoma 1 Ib T1bN0M0 Malignant
F1 51 F 41 Ovary Mucinous adenocarcinoma 3 Ib T1bN0M0 Malignant
F2 52 F 29 Ovary Mucinous adenocarcinoma 2 III T3N0M0 Malignant
F3 53 F 60 Ovary Mucinous adenocarcinoma 3 Ia T1aN0M0 Malignant
F4 54 F 47 Ovary Endometrioid adenocarcinoma 1 IIa T2aN0M0 Malignant
F5 55 F 54 Ovary Endometrioid adenocarcinoma 1 Ib T1bN0M0 Malignant
F6 56 F 46 Ovary Endometrioid adenocarcinoma 1 II T2N0M0 Malignant
F7 57 F 49 Ovary Endometrioid adenocarcinoma 1 I T1N0M0 Malignant
F8 58 F 43 Ovary Endometrioid adenocarcinoma 2 Ic T1cN0M0 Malignant
F9 59 F 60 Ovary Endometrioid adenocarcinoma 3 Ib T1bN0M0 Malignant
F10 60 F 53 Ovary Endometrioid adenocarcinoma 3 IIa T2aN0M0 Malignant
G1 61 F 39 Ovary Cancer adjacent normal ovary tissue NAT
G2 62 F 53 Ovary Cancer adjacent normal ovary tissue NAT
G3 63 F 30 Ovary Cancer adjacent normal ovary tissue NAT
G4 64 F 39 Ovary Cancer adjacent normal ovary tissue NAT
G5 65 F 17 Ovary Cancer adjacent normal ovary tissue NAT
G6 66 F 40 Ovary Cancer adjacent normal ovary tissue NAT
G7 67 F 45 Ovary Cancer adjacent normal ovary tissue NAT
G8 68 F 42 Ovary Cancer adjacent normal ovary tissue NAT
G9 69 F 41 Ovary Cancer adjacent normal ovary tissue NAT
G10 70 F 69 Ovary Cancer adjacent normal ovary tissue NAT
M 58 Skin Malignant melanoma (tissue marker) Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。